SMX (Security Matters) Public, Spring Valley Acquisition, Bitfarms, Direxion Daily GOOGL Bull 2X Shares, and Pasithea Therapeutics are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations—commonly defined as roughly $300 million to $2 billion, though exact cutoffs vary by index. For investors, they often offer higher growth potential but come with greater volatility, lower liquidity, and higher risk compared with larger, more established companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
SMX (Security Matters) Public (SMX)
SMX (Security Matters) Public Limited Company, through its subsidiaries, engages in the development and commercialization of track and trace technologies for various industries. It owns and commercializes technology to mark various objects, such as solid, liquid, or gas allowing identification, circularity, proof of authenticity, tracking supply chain movements, and quality assurance.
Read Our Latest Research Report on SMX
Spring Valley Acquisition (SV)
Read Our Latest Research Report on SV
Bitfarms (BITF)
Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. It owns and operates server farms that primarily validates transactions on the Bitcoin Blockchain and earning cryptocurrency from block rewards and transaction fees. The company also provides electrician services to commercial and residential customers in Quebec, Canada.
Read Our Latest Research Report on BITF
Direxion Daily GOOGL Bull 2X Shares (GGLL)
Read Our Latest Research Report on GGLL
Pasithea Therapeutics (KTTA)
Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications.
Read Our Latest Research Report on KTTA
Featured Stories
Before you consider SMX (Security Matters) Public, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SMX (Security Matters) Public wasn't on the list.
While SMX (Security Matters) Public currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.